当前市场环境动荡,但医疗设备制造商Penumbra Inc.依然在周三早盘大涨9.21%,股价一度涨至293.90美元。引发该股价大涨的主要原因是该公司第四季度业绩优异且分析师看好其未来前景。
Penumbra昨日公布第四季度营收达3.15亿美元,同比增长10.8%,超出分析师预期的3.11亿美元。公司正在多个利基领域快速发展,业绩表现强劲。
财报理想导致多家分析机构上调对Penumbra的目标价和评级。包括BTIG、Canaccord Genuity、摩根大通等14家机构上调目标价,目标价中位数达308美元,最高预期340美元。多数分析师认为公司今年销售增长将保持中高水平,利润率也将大幅提高,未来发展前景看好。看涨情绪推动Penumbra股价大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.